PAYMENT RATE CUTS FOR CLINICAL LABORATORY TESTS, called for under the Protecting Access to Medicare Act of 2014 (PAMA), have been avoided temporarily—again. A down-to-the-wire bill in Congress to keep the federal government funded into the new year included a provision to delay PAMA cuts to the Clinical Laboratory Fee Schedule (CLFS) for 2023. This […]
PAMA Cuts Have Simply Been Kicked Down the Road
PAYMENT RATE CUTS FOR CLINICAL LABORATORY TESTS, called for under the Protecting Access to Medicare Act of 2014 (PAMA), have been avoided temporarily—again. A down-to-the-wire bill in Congress to keep the federal government funded into the new year included a provision to delay PAMA cuts to the Clinical Laboratory Fee Schedule (CLFS) for 2023. This […]
Comments
Volume XXX, No. 1 – January 3, 2023
TABLE OF CONTENTS
COMMENTARY & OPINION BY R. LEWIS DARK
ARTICLES
INTELLIGENCE
Need A Group Membership? Company Discounts are Available!